ArticleHematology reports2024

Phase II Trial of Romidepsin as Consolidation Therapy after Gemcitabine, Dexamethasone, and Cisplatin in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma.

Satoshi Yamasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.